Malignant solitary fibrous tumor in the central nervous system treated with surgery, radiotherapy and anlotinib: A case report

doi:10.12998/wjcc.v10.i2.631

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 2

This Article

(236)

(205)

(0)

(13)

(1)

(5272)

(4)

Peer-Review Report of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Report

World J Clin Cases. Jan 14, 2022; 10(2): 631-642
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.631

Full Size Figure Download Figure

Figure 3 Circos 2D track plot of somatic variant across chromosomes in solitary fibrous tumor. In the inner ring, black denotes missense mutation, blue denotes frameshift mutation, and red denotes gene amplification.

Citation: Zhang DY, Su L, Wang YW. Malignant solitary fibrous tumor in the central nervous system treated with surgery, radiotherapy and anlotinib: A case report. World J Clin Cases 2022; 10(2): 631-642
URL: https://www.wjgnet.com/2307-8960/full/v10/i2/631.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.631

Zhang DY, Su L, Wang YW. Malignant solitary fibrous tumor in the central nervous system treated with surgery, radiotherapy and anlotinib: A case report. World J Clin Cases 2022; 10(2): 631-642 [PMID: 35097089 DOI: 10.12998/wjcc.v10.i2.631]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.